| 摘要 |
<p>The subject of the present invention is the use of bacitracin for the hydrolytic degradation of RNA, occurring at guanosine residues, preferably in single-stranded RNA regions, and occurring without the involvement of transition metal ions. According to the invention, it is possible to use bacitracin according to a mechanism dependent on the degradation of undesirable RNA, different than that stipulated to-date.</p> |
| 申请人 |
WROCLAWSKIE CENTRUM BADAN EIT+ SP. Z O.O. |
发明人 |
CIESIOLKA, JERZY;JEZOWSKA-BOJCZUK, MALGORZATA;WRZESINSKI, JAN;NAGAJ, JUSTYNA;STOKOWA-SOLTYS, KAMILA;KASPROWICZ, ALEKSANDRA;BLASZCZYK, LESZEK;SZCZEPANIK, WOJCIECH |
